Zhengye biotechnology holding limited receives nasdaq notice related to late filing of form 20-f

Jilin, china, may 23, 2025 (globe newswire) -- zhengye biotechnology holding limited (nasdaq: zybt) (the “company” or “zhengye”), a veterinary vaccine manufacturer that encompasses research, development, manufacturing, and sales of veterinary vaccines, with a focus on livestock vaccines in china, today announced that it has received a letter from the nasdaq stock market, dated may 20, 2025 (the “delinquency letter”), notifying the company that it is not in compliance with the requirements for continued listing set forth in nasdaq listing rule 5250(c)(1) because it did not timely file its annual report on form 20-f for the fiscal year ended december 31, 2024 (the “2024 annual report”).
ZYBT Ratings Summary
ZYBT Quant Ranking